Global Hairy Cell Leukemia Pipeline Insights Report 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Hairy Cell Leukemia - Pipeline Insights, 2017" drug pipelines to their offering.

Hairy Cell Leukemia - Pipeline Insights, 2017 provides in depth insights on the pipeline drugs and their development activities around the Hairy Cell Leukemia. This report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. This report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Hairy Cell Leukemia.

This report also assesses the Hairy Cell Leukemia therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Scope:

  • The report provides competitive pipeline landscape of Hairy Cell Leukemia
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Hairy Cell Leukemia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Hairy Cell Leukemia and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  • Hairy Cell Leukemia Overview
  • Hairy Cell Leukemia Pipeline Therapeutics
  • Hairy Cell Leukemia Therapeutics under Development by Companies
  • Hairy Cell Leukemia Filed and Phase III Products
  • Hairy Cell Leukemia Phase II Products
  • Hairy Cell Leukemia Phase I and IND Filed Products
  • Hairy Cell Leukemia Discovery and Pre-Clinical Stage Products
  • Drug Candidate Profiles
  • Hairy Cell Leukemia - Therapeutics Assessment
  • Companies Involved in Therapeutics Development for Hairy Cell Leukemia
  • Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/m6bngl/hairy_cell

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Leukemia Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Leukemia Drugs